tiprankstipranks
Immunome files to sell 1.8M shares of common stock for holders
PremiumThe FlyImmunome files to sell 1.8M shares of common stock for holders
2M ago
Immunome price target lowered to $21 from $23 at Piper Sandler
Premium
The Fly
Immunome price target lowered to $21 from $23 at Piper Sandler
3M ago
Immunome, Inc. Reports Q3 2024 Financial Results
Premium
Company Announcements
Immunome, Inc. Reports Q3 2024 Financial Results
3M ago
Immunome initiated with an Overweight at Stephens on ‘seasoned leadership’
PremiumThe FlyImmunome initiated with an Overweight at Stephens on ‘seasoned leadership’
3M ago
Immunome Advances with Strategic Asset Acquisition and Agreement
Premium
Company Announcements
Immunome Advances with Strategic Asset Acquisition and Agreement
3M ago
Immunome presents preclinical data for IM-1021, ADC payload HC74
Premium
The Fly
Immunome presents preclinical data for IM-1021, ADC payload HC74
3M ago
Immunome reports Q2 EPS (60c), consensus (39c)
PremiumThe FlyImmunome reports Q2 EPS (60c), consensus (39c)
6M ago
Immunome provides update, sees recent transactions improving ADC capabilities
Premium
The Fly
Immunome provides update, sees recent transactions improving ADC capabilities
6M ago
Immunome appoints Phil Tsai as Chief Technical Officer
Premium
The Fly
Immunome appoints Phil Tsai as Chief Technical Officer
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100